Pablo Legorreta: Pioneer of Pharmaceutical Royalties, Financial Innovator, and Founder and CEO of Royalty Pharma
Pablo Legorreta is a pioneer in pharmaceutical royalties and financial innovation, transforming the biopharmaceutical industry through his company Royalty Pharma. Under his leadership, Royalty Pharma has grown to become the world's largest buyer of pharmaceutical royalties, deploying over $25 billion in capital to advance innovation in the drug development ecosystem.
Pablo Legorreta founded Royalty Pharma in 1996, creating a new business model that has transformed the biopharmaceutical industry. He has deployed over $25 billion in capital to advance innovation in drug development. Legorreta's career began in investment banking at Lazard Frères, where he worked for a decade. He then founded Royalty Pharma, which has become the world's largest buyer of pharmaceutical royalties. The company has enabled blockbuster medicines to reach patients faster while generating returns for investors. Legorreta's vision has improved human health through financial innovation.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.